ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 684322 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 684322; 2) Community: the network communities that were significantly associated with the response to NSC 684322; 3) Molecule: the relationships between components within communities and NSC 684322; 4) MDR: the compounds that were significantly associated with the NSC 684322.

NSC Compound Enrichment Correlation
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0414190425892871 0.38769171
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0414190425892871 0.30436608
NSC 732178 Null 0.0414190425892871 0.32291134
NSC 733467 Null 0.0414190425892871 0.422288
NSC 733503 cis-6-(3-Bromopropyl)-12,13-dihydro-8,9-dimethoxy-3-nitro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0414190425892871 0.34567544
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0414190425892871 0.35471756
NSC 740 Methotrexate 0.0414190425892871 0.34445383
NSC 743530 Null 0.0414190425892871 0.35797256
NSC 759178 Pipamperone 0.0414190425892871 0.29241512
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0414190425892871 0.32006178
Total:76  Current:66    [First] [Prev] [Next] [Last]